- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03692845
Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion
October 1, 2018 updated by: Amr Hatem Ahmed Mohammed, Assiut University
A study that compares between Open TLIF and Minimally invasive TLIF regarding patients' functional status(Oswestry Disability index)as a primary outcome measure.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The first randomized controlled trial comparing minimally invasive TLIF and open TLIF.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults more than 18 years of age and less than 65 years of age..
- Degenerative or isthmic spondylolithesis Grade 1,2 and 3.
- Recurrent Symptomatic recurrent lumbar disc prolapsed with or without evident neural compression.
- Single level pathology involving L2-3, L3-4, L4-5 and or L5-S1.
- Symptoms not responding to conservative treatment for at least 3 months.
Exclusion Criteria:
- Previous spinal fusion or instrumentation.
- Spinal tumours, infection and fractures.
- Patients with severe osteoporosis
- BMI more than 35.
- Non-ambulant patients and patients with severe preoperative neurological affection (Cauda Equina Syndrome)
- Patients not willing to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: O-TLIF group
Spinal fusion ,Transforaminal lumbar interbody fusion procedure will be performed through open surgery.
|
Spinal fusion procedure through the intervertebral foramen
|
|
Other: MI-TLIF group
Spinal fusion,Transforaminal lumbar interbody fusion procedure will be performed through minimally invasive surgery using a tubular retractor.
|
Spinal fusion procedure through the intervertebral foramen
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oswestry Disability index(Arabic version) 1 month
Time Frame: 1 month
|
an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain.
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
• Fusion rate as assessed by Bridwell fusion score.
Time Frame: 1 year
|
Grade I is defined as fusion with remodelling and trabeculae present; Grade II is an intact graft with incomplete remodelling and no lucency present; Grade III is an intact graft with potential lucency at the cranial or caudal end; Grade IV is absent fusion with collapse/resorption of the graft.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
November 1, 2018
Primary Completion (Anticipated)
November 1, 2020
Study Completion (Anticipated)
October 1, 2021
Study Registration Dates
First Submitted
September 28, 2018
First Submitted That Met QC Criteria
October 1, 2018
First Posted (Actual)
October 2, 2018
Study Record Updates
Last Update Posted (Actual)
October 2, 2018
Last Update Submitted That Met QC Criteria
October 1, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 6272829
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Fusion
-
Xtant MedicalRTI SurgicalRecruitingJoint Diseases | Musculoskeletal Diseases | Spinal Stenosis | Fusion of Spine | Spine | Spinal Fusion | Spinal Disease | Spinal Instability | Sacroiliac; Fusion | Fusion of Joint | SacroiliacUnited States, Spain, Germany
-
National Taiwan University HospitalTerminatedLumbar Fusion | Lumbar Spinal Fusion SurgeryTaiwan
-
The Second Hospital of Shandong UniversityNot yet recruiting
-
Chi Mei Medical HospitalActive, not recruiting
-
Exela Pharma Sciences, LLC.Terminated
-
Gia Dinh People HospitalCompletedSpinal FusionVietnam
-
Mayo ClinicCompleted
-
George Papanicolaou HospitalCompleted
-
AO Foundation, AO SpineRecruitingSpinal FusionUnited States, Japan, Spain, Canada, China, India, Turkey (Türkiye)
-
M.C. Kruyt, MD, PhDKuros BioSciences B.V.CompletedSpinal FusionNetherlands
Clinical Trials on Transforaminal Lumbar Interbody Fusion either open or minimally invasive
-
Copernicus Memorial HospitalRecruitingLumbar Disc Degeneration | Lower Back Pain Chronic | Degenerative Disc Disease(DDD) | Lumbar Degenerative DiseasePoland
-
The First People's Hospital of LianyungangNot yet recruitingSpinal Stenosis Lumbar
-
Aesculap AGActive, not recruitingDisk Herniated Lumbar | Spondylolisthesis | Disc Disease DegenerativeGermany
-
The London Spine CentreUnknownDegenerative Lumbar SpondylolisthesisCanada
-
Pei-Yuan Lee, MDAeon Biotechnology CorporationUnknownSpinal Fusion | Bone MarrowTaiwan
-
ExactechTerminatedDegenerative Disc Disease | Spondylolisthesis | StenosisUnited States
-
Spine and Scoliosis Research AssociatesCompletedDegenerative Disc Disease (DDD)United States
-
Premia SpineCompletedLumbar Spinal Stenosis | Degenerative SpondylolisthesisUnited States
-
Justin Parker Neurological InstituteCompletedDegenerative Disc DiseaseUnited States
-
Medtronic Spinal and BiologicsCompletedIntervertebral Disc DegenerationUnited Kingdom, Belgium, Germany, China, Spain, Austria, Argentina, Brazil, Czechia, France, Italy, Mexico, Portugal, Slovakia, Denmark, Russia, South Korea